This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
If there's a silver lining to the COVID pandemic, it might be that it encourages U.S. manufacturers to consider reshoring. Last year's shortages of personal protective equipment, ventilators, pharmaceutical ingredients and other medical products opened a lot of eyes in board rooms and in Washington.
Since 2010, more than 4,700 companies have brought back some or all of their manufacturing operations and sourcing to the U.S. Despite COVID-19, reshoring was up in 2020.
BRUSSELS—The COVID-19 pandemic has sparked the biggest decline in car production in Europe on record, according to data published last week by the European Automobile Manufacturers Association.
General Motors has announced that its Factory ZERO has become the first automotive plant in the U.S. to install dedicated 5G fixed mobile network technology.
COVID-19 has accelerated deglobalization in manufacturing, but that shift was already underway before the pandemic. Between 1990 and 2016, global trade had been growing at average annual rate of 4.9 percent, according to the World Trade Organization.
LOUISVILLE—Approximately 20,000 active and retired Ford factory workers, their immediate family members and surviving spouses will be able to get coronavirus tests at the UAW hall here after the union’s executive board voted unanimously to hire a private laboratory to perform the tests at no cost to members.
BOXBOROUGH, MA—German contract manufacturer Vibalogics GmbH is investing $150 million and hiring 100 people for a facility here to help Big Pharma develop a COVID-19 vaccine. The company plans to open the site by the second half of 2021.
